⌘K

Login Start Free

Home/Filings/4/0001437749-24-035872

4//SEC Filing

Landen Jaren 4

Accession 0001437749-24-035872

CIK 0001069530other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:39 PM ET

Size

5.2 KB

Accession

0001437749-24-035872

Insider Transaction Report

Form 4

Period: 2024-11-18

CASSAVA SCIENCES INCSAVA

Chief Clinical Dev. Officer

Transactions

Award
Stock Option (Right to Buy)
2024-11-18+85,000→ 85,000 total
Exercise: $27.95Exp: 2034-11-18→ Common Stock (85,000 underlying)

Footnotes (1)

[F1]The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

CASSAVA SCIENCES INC

CIK 0001069530

Entity typeother

Related Parties

1

filerCIK 0002045287

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 4:39 PM ET
Size: 5.2 KB

View on SEC.gov